Anzeige
Mehr »
Dienstag, 17.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.329 Leser
Artikel bewerten:
(2)

Delisting of Securities of Core Scientific, Inc.; The Very Good Food Company Inc.; HyreCar Inc.; Reeds, Inc.; Sorrento Therapeutics, Inc.; CYREN Ltd.; Lucira Health, Inc.; Qutoutiao Inc.; and Sio Gene Therapies Inc. from The Nasdaq Stock Market

NEW YORK, April 10, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the common stock and warrant of Core Scientific, Inc. Core Scientific, Inc. securities were suspended on January 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common shares of The Very Good Food Company Inc. The Very Good Food Company Inc. common shares were suspended on January 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of HyreCar Inc. HyreCar Inc.'s common stock was suspended on February 3, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Reeds, Inc. Reeds, Inc.'s common stock was suspended on February 16, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Sorrento Therapeutics, Inc. Sorrento Therapeutics, Inc.'s common stock was suspended on February 23, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the ordinary shares of CYREN Ltd. CYREN Ltd. ordinary shares were suspended on March 3, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Lucira Health, Inc. Lucira Health, Inc. common stock was suspended on March 6, 2023, and has not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the American Depositary Shares of Qutoutiao Inc. Qutoutiao Inc. shares were suspended on March 23, 2023, and have not traded on Nasdaq since that time.

Nasdaq also announced today that it will delist the common stock of Sio Gene Therapies Inc. Sio Gene Therapies Inc. common stock was suspended on March 23, 2023, and has not traded on Nasdaq since that time.

Nasdaq will file a Form 25 with the Securities and Exchange Commission to complete the delistings. The delistings become effective ten days after the Form 25 is filed. For news and additional information about the companies, including the basis for the delisting and whether the companies' securities are trading on another venue, please review the companies' public filings or contact the company directly.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq's rules governing the delisting of securities can be found in the Nasdaq Rule 5800 Series, available on the Nasdaq Web site: https://listingcenter.nasdaq.com/rulebook/nasdaq/rules/nasdaq-5800-series.

-NDAQO-


© 2023 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.